This application addresses NIMH broad Challenge Area (04) """"""""Clinical Research"""""""" and specific challenge topic 04-MH-102: """"""""refining categories of clinical phenotypes for mental health research purposes"""""""". We propose an innovative study aimed at refining and validating a clinical phenotype for """"""""paternal age related schizophrenia"""""""" (PARS). Paternal age may account for >25% of all cases of schizophrenia and a higher portion of cases in active treatment. This work is aimed at the heterogeneity of schizophrenia, which limits efforts to optimize treatment and to achieve prevention and cure. This heterogeneity is rarely met directly. Genetic studies employ huge sample sizes and clinical researchers target cognitive or negative symptom domains, which are found across the disorder and are associated with adverse outcomes. However, the neural origins and optimum treatment of these domains may differ crucially between schizophrenia subgroups. Potentially progressive and/or remediable substrates remain obscured by heterogeneity. In post hoc analyses (from our earlier-funded NIMH CMHC in Schizophrenia) we found that sporadic cases with paternal age >35 years (a proxy for PARS) had distinct patterns of symptoms, cognition, course and sex-differences versus other (NonPARS) cases. The subgroups also differed in neural circuitry;PARS had lower metabolism in cingulate/paracingulate cortices and the inferior frontal region than controls or the other cases. Congruently, decreasing prefrontal N-Acetyl Acetate on magnetic resonance spectroscopy (MRS) was associated with advancing paternal age in sporadic cases. We propose to prospectively characterize 40 PARS and 40 NonPARS schizophrenia cases and 20 healthy controls. We will assess clinical measures, quality of life, moderating exposures, and other risk factors and obtain neuroimaging data with a 3T (and up to a 7T) MRI/MRS. We will compare features of the anterior cingulate and hippocampus across the groups, controlling for individual BDNF (val66met) haplotype, which is associated with schizophrenia and influences neuroanatomy. We will identify the specific dimensions of cognition and behavior in PARS that map on to particular brain circuitry. Sophisticated data analytic techniques will be used to validate the clinical phenotype of PARS. Genetic samples will also be used in the future to validate the genetic substrates of PARS that we identify in 3R01MH059114 (Jerusalem Perinatal Cohort Schizophrenia Study) or which are nominated by other research efforts. This study is ready to be launched immediately at a large public hospital that serves a diverse and underserved population. The etiology and neurobiological underpinnings of schizophrenia may plausibly differ between latent discrete subgroups of cases. By refining and validating a clinical phenotype for PARS, we will create novel opportunities for tailored treatment interventions in a large portion of cases and we will also have a key phenotype for genetic research. Schizophrenia is a devastating chronic illness with an onset in young adulthood, typically causing deterioration and life long disability. Treatment approaches for schizophrenia are limited due to the heterogeneity of this disease. This project will categorize Paternal Age Related Schizophrenia (PARS) and probe the neurobiological and genetic underpinnings of this phenotype.

Public Health Relevance

Schizophrenia is a devastating chronic illness with an onset in young adulthood, typically causing deterioration and life long disability. Treatment approaches for schizophrenia are limited due to the heterogeneity of this disease. This project will categorize Paternal Age Related Schizophrenia (PARS) and probe the neurobiological and genetic underpinnings of this phenotype.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
NIH Challenge Grants and Partnerships Program (RC1)
Project #
5RC1MH088843-02
Application #
7936854
Study Section
Special Emphasis Panel (ZRG1-BDCN-T (58))
Program Officer
Morris, Sarah E
Project Start
2009-09-30
Project End
2011-08-31
Budget Start
2010-09-10
Budget End
2011-08-31
Support Year
2
Fiscal Year
2010
Total Cost
$483,719
Indirect Cost
Name
New York University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Walsh-Messinger, Julie; Wong, Philip S; Antonius, Daniel et al. (2018) Sex differences in hedonic judgement of odors in schizophrenia cases and healthy controls. Psychiatry Res 269:345-353
Joe, Peter; Getz, Mara; Redman, Samantha et al. (2018) Transglutaminase-5 related schizophrenia. Schizophr Res 193:477-479
Kranz, Thorsten M; Berns, Adam; Shields, Jerry et al. (2016) Phenotypically distinct subtypes of psychosis accompany novel or rare variants in four different signaling genes. EBioMedicine 6:206-214
Malaspina, Dolores; Kranz, Thorsten M; Heguy, Adriana et al. (2016) Prefrontal neuronal integrity predicts symptoms and cognition in schizophrenia and is sensitive to genetic heterogeneity. Schizophr Res 172:94-100
Mazgaj, Robert; Tal, Assaf; Goetz, Raymond et al. (2016) Hypo-metabolism of the rostral anterior cingulate cortex associated with working memory impairment in 18 cases of schizophrenia. Brain Imaging Behav 10:115-23
Malaspina, Dolores; Walsh-Messinger, Julie; Antonius, Daniel et al. (2016) Parental age effects on odor sensitivity in healthy subjects and schizophrenia patients. Am J Med Genet B Neuropsychiatr Genet 171:513-20
Meyer, E J; Kirov, I I; Tal, A et al. (2016) Metabolic Abnormalities in the Hippocampus of Patients with Schizophrenia: A 3D Multivoxel MR Spectroscopic Imaging Study at 3T. AJNR Am J Neuroradiol 37:2273-2279
Daskalakis, Nikolaos P; De Kloet, Edo Ronald; Yehuda, Rachel et al. (2015) Early Life Stress Effects on Glucocorticoid-BDNF Interplay in the Hippocampus. Front Mol Neurosci 8:68
Malaspina, Dolores; Gilman, Caitlin; Kranz, Thorsten Manfred (2015) Paternal age and mental health of offspring. Fertil Steril 103:1392-6
Milekic, M H; Xin, Y; O'Donnell, A et al. (2015) Age-related sperm DNA methylation changes are transmitted to offspring and associated with abnormal behavior and dysregulated gene expression. Mol Psychiatry 20:995-1001

Showing the most recent 10 out of 28 publications